During the past decade, Linyi People's Hospital conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 2 clinical trials were completed, i.e. on average, 6.9% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 2 clinical trials were completed. i.e. 13.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Linyi People's Hospital" #1 sponsor was "Shandong Provincial Hospital" with 4 trials, followed by "Beijing Tiantan Hospital" with 3 trials sponsored, "Capital Medical University" with 2 trials sponsored, "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 2 trials sponsored and "Guangdong Raynovent Biotech Co., Ltd" with 2 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Linyi People's Hospital" #1 collaborator was "Linyi People's Hospital" with 5 trials as a collaborator, "The First Hospital of Jilin University" with 5 trials as a collaborator, "Baotou Central Hospital" with 4 trials as a collaborator, "Beijing Tiantan Hospital" with 4 trials as a collaborator and "Qilu Hospital of Shandong University" with 4 trials as a collaborator. Other collaborators include 201 different institutions and companies that were collaborators in the rest 132 trials.

According to Clinical.Site data, the most researched conditions in "Linyi People's Hospital" are "Acute Ischemic Stroke" (4 trials), "Ischemic Stroke" (3 trials), "Familial Alzheimer Disease (FAD)" (2 trials), "Influenza A" (2 trials) and "Intracranial Atherosclerosis" (2 trials). Many other conditions were trialed in "Linyi People's Hospital" in a lesser frequency.

Most popular intervention types in "Linyi People's Hospital" are "Drug" (23 trials), "Other" (8 trials), "Device" (6 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Anlotinib" (2 trials), "placebo" (2 trials), "ABY-035" (1 trials) and "Acarbose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Linyi People's Hospital" are 34 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Linyi People's Hospital". 2 are not yet recruiting, 6 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Linyi People's Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Linyi People's Hospital, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 4 trials that are defined as “Not Applicable".